US 8772495
5-lipoxygenase-activating protein inhibitor
granted A61KA61K31/444A61P
Quick answer
US patent 8772495 (5-lipoxygenase-activating protein inhibitor) held by Panmira Pharmaceuticals, LLC expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Panmira Pharmaceuticals, LLC
- Grant date
- Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/444, A61P, A61P1/04, A61P11/00